AIVITA Biomedical’s Phase 2 Glioblastoma Trial Shows Improved Progression Free Survival

Personalized cancer vaccine reduces risk of disease progression or death by 38% IRVINE, Calif., Nov. 17, 2020 /PRNewswire/ — AIVITA Biomedical, Inc., a private biotechnology company specializing in innovative stem cell applications, today announced data from its multi-center Phase 2 clinical trial of its personalized cancer vaccine, AV-GBM-1, in patients with newly diagnosed glioblastoma (GBM). The … Continued

Read More

AIVITA Biomedical Completes Treatment of Patients in Phase 2 Clinical Trial of Glioblastoma Immunotherapy

— 94% manufacturing success rate achieved for personalized cancer immunotherapy development — IRVINE, Calif., Nov. 2, 2020 /PRNewswire/ — AIVITA Biomedical, Inc., a private biotechnology company specializing in innovative stem cell applications, announced today that treatment has been completed for all 57 patients in the Phase 2 clinical trial of AV-GBM-1 in patients with glioblastoma. The … Continued

Read More

AIVITA Biomedical Publishes Review of GM-CSF History and Rationale as Vaccine Adjuvant in Melanoma Management

IRVINE, Calif., Aug. 3, 2020 /PRNewswire/ — AIVITA Biomedical, Inc., a private biotechnology company developing personalized vaccines for the treatment of cancer and prevention of COVID-19, announced today the publication of the paper, “An update on GM-CSF and its potential role in melanoma management,” in the journal Melanoma Management. Robert O. Dillman, M.D., chief medical officer at … Continued

Read More

MariaDB Platform X5 Adds New Distributed SQL

REDWOOD CITY, Calif. and HELSINKI – July 16, 2020 – MariaDB® Corporation today announced the general availability of MariaDB Platform X5, a comprehensive open source database solution delivering the ultimate in versatility across workloads and scalability from a single database or data warehouse to millions of transactions per second. This major release introduces powerful upgrades … Continued

Read More

MariaDB Gives the Power of Analytics to Millions for Free

MariaDB Community Server 10.5 turns into analytics powerhouse with cloud-native storage REDWOOD CITY, Calif. and HELSINKI – June 24, 2020 – MariaDB® Corporation today announced the general availability of MariaDB Community Server 10.5, a major new release that brings high-performance analytics to the hands of millions using the popular open source database. In a push … Continued

Read More

Razer announces Kishi

Original Article from The Verge In October, Razer announced Junglecat, a mobile gamepad with two Nintendo Switch Joy-Con-like controllers that attached to either side of your phone, but it only worked with four Android phones and required that you put your phones in a special case when you used it. Today at CES, just a few … Continued

Read More

MariaDB SkySQL Adds ‘Power Tier’ for Enterprises That Demand Distinction

REDWOOD CITY, Calif. and HELSINKI – May 13, 2020 – MariaDB® Corporation today announced the immediate availability of MariaDB SkySQL Power, the first database-as-a-service (DBaaS) offering that lets enterprises customize options and configurations to fit their distinct requirements. Built on top of SkySQL’s Foundation, which delivers the complete MariaDB Platform experience in the cloud, Power … Continued

Read More

AIVITA Biomedical Presents Updates from Ongoing Ovarian Cancer and Glioblastoma Clinical Studies at 2020 AACR Virtual Annual Meeting

IRVINE, Calif.–(BUSINESS WIRE)– AIVITA Biomedical, Inc., a biotechnology company specializing in innovative cell therapy applications, announced today that updates from ongoing clinical trials in ovarian cancer and glioblastoma were presented as part of the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting I. The presentation from Daniela Bota, MD, Ph.D., of the University … Continued

Read More

AIVITA Biomedical Raises $12.5 Million in Series B-2 Financing Round and Announces New Board of Directors Appointee

Leader of Series B-2 Financing Round Matthew Katz Joins AIVITA’s Board of Directors IRVINE, Calif., Feb. 25, 2020 /PRNewswire/ — AIVITA Biomedical, Inc., a biotechnology company (the “Company”) specializing in innovative stem cell applications, announced today the first closing of its $25 million Series B-2 preferred stock investment round. The first closing of $12.5 million was … Continued

Read More